Immunotherapy with internally inactivated virus loaded dendritic cells boosts cellular immunity but does not affect feline immunodeficiency virus infection course

Retrovirology

Volumn 5, Issue , 2008, Pages

  Freer, Giulia ^a   Matteucci, Donatella ^a   Mazzetti, Paola ^a   Tarabella, Francesca ^a   Ricci, Enrica ^a   Bozzacco, Leonia ^a   Merico, Antonio ^a   Pistello, Mauro ^a   Ceccherini Nelli, Luca ^a   Bendinelli, Mauro ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INACTIVATED VACCINE; VIRUS VACCINE;

ADOPTIVE IMMUNOTHERAPY; ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; FELINE IMMUNODEFICIENCY VIRUS; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MONOCYTE; NONHUMAN; T CELL DEPLETION; VIREMIA; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS LOAD; ANIMAL; CAT; CAT DISEASE; CELL PROLIFERATION; CYTOLOGY; IMMUNOLOGY; IMMUNOTHERAPY; METHODOLOGY; PHYSIOLOGY; VIROLOGY;

FELINE IMMUNODEFICIENCY VIRUS;

ANIMALS; CATS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DENDRITIC CELLS; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; IMMUNITY, CELLULAR; IMMUNODEFICIENCY VIRUS, FELINE; IMMUNOTHERAPY; VACCINES, INACTIVATED; VIRAL LOAD; VIRAL VACCINES;

EID: 43149087071     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-5-33     Document Type: Article

References (20)

1. Heeney JL Plotkin SA Immunological correlates of protection from HIV infection and disease Nat Immunol 2006, 7(12):1281-1284. 10.1038/ ni1206-1281 17110946
2. Sallusto F Lanzavecchia A The instructive role of dendritic cells on T-cell responses Arthritis Res 2002, 4(3):127-132. 10.1186/ar567 12110131
3. Steinman RM Banchereau J Taking dendritic cells into medicine Nature 2007, 449(7161):419-426. 10.1038/nature06175 17898760
4. Nencioni A Grünebach F Schmidt SM Müller MR Boy D Patrone F Ballestrero A Brossart P The use of dendritic cells in cancer immunotherapy Crit Rev Oncol Hematol 2008, 65(3):191-199. 10.1016/ j.critrevonc.2007.10.002 18055210
5. Lu W Wu X Lu Y Guo W Andrieu JM Therapeutic dendritic-cell vaccine for simian AIDS Nat Med 2003, 9(1):27-32. 10.1038/nm806 12496959
6. Lu W Arraes LC Ferreira WT Andrieu JM Therapeutic dendritic-cell vaccine for chronic HIV-1 infection Nat Med 2004, 10(12):1359-1365. 10.1038/ nm1147 15568033
7. Sparger E FIV as a model for HIV: An overview Infectious Agents and Pathogenesis: In vivo models of HIV disease and Control Springer. New York Friedman H, Specter S, Bendinelli M 2006 149-199
8. Freer G Matteucci D Mazzetti P Tarabella F Catalucci V Ricci E Merico A Bozzacco L Pistello M Bendinelli M Evaluation of feline monocyte-derived dendritic cells loaded with internally inactivated virus as a vaccine against feline immunodeficiency virus Clin Vaccine Immunol 2008, 15(3):452-459. 10.1128/CVI.00421-07 18216184
9. Whitmire JK Murali-Krishna K Altman J Ahmed R Antiviral CD4 and CD8 T-cell memory: Differences in the size of the response and activation requirements Philos Trans R Soc Lond B Biol Sci 2000, 355(1395):373-379. 1692741 10794058 10.1098/rstb.2000.0577
10. Matteucci D Pistello M Mazzetti P Giannecchini S Del Mauro D Zaccaro L Bandecchi P Tozzini F Bendinelli M Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies J Virol 1996, 70(1):617-622. 189855 8523581
11. Freer G Matteucci D Mazzetti P Bozzacco L Bendinelli M Generation of feline dendritic cells derived from peripheral blood monocytes for in vivo use Clin Diagn Lab Immunol 2005, 12(10):1202-1208. 1247835 16210484 10.1128/CDLI.12.10.1202-1208.2005
12. Nair S McLaughlin C Weizer A Su Z Boczkowski D Dannull J Vieweg J Gilboa E Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation J Immunol 2003, 171(11):6275-6282. 14634145
13. Figdor CG de Vries IJ Lesterhuis WJ Melief CJ Dendritic cell immunotherapy: Mapping the way Nat Med 2004, 10(5):475-480. 10.1038/ nm1039 15122249
14. Gill VL Bergman PJ Baer KE Craft D Leung C Use of imiquimod 5% cream (Aldara™) in cats with multicentric squamous cell carcinoma in situ 12 cases (2002-2005) Vet Comp Oncol 2008, 6(1):55-64. 10.1111/ j.1476-5829.2007.00144.x
15. Pistello M Moscardini M Mazzetti P Macchi S Bonci F Isola P Freer G Matteucci D Specter S Bendinelli M Development of feline immunodeficiency virus ORF-A (tat) mutants: In vitro and in vivo characterization Virology 2002, 298(1):84-95. 10.1006/viro.2002.1442 12093176
16. Sekaly RP The failed HIV Merck vaccine study: A step back or launching point for future vaccine development? J Exp Med 2008, 205(1):7-12. 10.1084/jem.20072681 18195078
17. Recher M Lang KS Navarini A Hunziker L Lang PA Fink K Freigang S Georgiev P Hangartner L Zellweger R Bergthaler A Hegazy AN Eschli B Theocharides A Jeker LT Merkler D Odermatt B Hersberger M Hengartner H Zinkernagel RM Extralymphatic virus sanctuaries as a consequence of potent T-cell activation Nature Medicine 2007, 13(11):1316-1323. 10.1038/ nm1670 17982463
18. Loh L Petravic J Batten CJ Davenport MP Kent SJ Vaccination and timing influence SIV immune escape viral dynamics in vivo PLoS Pathog 2008, 4(1):e12. 2323283 18225952 10.1371/journal.ppat.0040012
19. O'Rourke MG Johnson M Lanagan C See J Yang J Bell JR Slater GJ Kerr BM Crowe B Purdie DM Elliott SL Ellem KA Schmidt CW Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine Cancer Immunol Immunother 2003, 52(6):387-395. 12682787
20. Tacken PJ de Vries IJ Torensma R Figdor CG Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting Nat Rev Immunol 2007, 7(10):790-802. 10.1038/nri2173 17853902